4//SEC Filing
Deignan Charles A. 4
Accession 0001209191-24-001959
CIK 0001539029other
Filed
Jan 18, 7:00 PM ET
Accepted
Jan 19, 6:25 PM ET
Size
8.2 KB
Accession
0001209191-24-001959
Insider Transaction Report
Form 4
Deignan Charles A.
Chief Financial Officer
Transactions
- Sale
Common Stock
2024-01-19$1.28/sh−12,900$16,512→ 384,662 total - Award
Employee Stock Option (right to buy)
2024-01-18+200,000→ 200,000 totalExercise: $1.29Exp: 2034-01-18→ Common Stock (200,000 underlying)
Footnotes (3)
- [F1]The sales reported in this Form 4 represents shares required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the settlement of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a "sell to cover" transaction.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.18 to $1.32 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]One-fourth of the shares underlying this option vest on January 18, 2025 and the balance of the shares vest in a series of 36 successive equal monthly installments thereafter, subject to the Reporting Person's continuous service as of each such vesting date.
Documents
Issuer
Clearside Biomedical, Inc.
CIK 0001539029
Entity typeother
Related Parties
1- filerCIK 0001664690
Filing Metadata
- Form type
- 4
- Filed
- Jan 18, 7:00 PM ET
- Accepted
- Jan 19, 6:25 PM ET
- Size
- 8.2 KB